Immunos raises $15M for multitasking immune-activating agents Dec. 10, 2019 By Cormac Sheridan No Comments DUBLIN – Immunos Therapeutics AG raised CHF15 million (US$15.2 million) in a series A round to move a novel immuno-oncology platform designed to turn cold tumors hot into early clinical development.Read More